We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Low Grade Inflammation in Type 1 Diabetes Children (Coccinelle)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01099956
Recruitment Status : Completed
First Posted : April 8, 2010
Last Update Posted : October 25, 2011
Information provided by (Responsible Party):
University Hospital, Bordeaux

Brief Summary:
The study propose to measure the inflammation level in type 1 diabetes children with the cytokine analysis compared to non diabetic children of the same sibling and to healthy children.

Condition or disease
Type 1 Diabetes Inflammation

Detailed Description:

The increase of type 1 diabetes incidence, particularly in young children leads to conduce new diagnostic and therapeutic strategies, notably for associated chronic morbidity.Measurement of chronic inflammation, with modification of the balance between pro-inflammatory cytokines and anti-inflammatory cytokines, could lead to detect patients with high risk to diabetes chronic morbidity.

After parental consent, blood sampling will be carried out by micromethod for cytokine (500 µl) and CRPhs dosages and glycemia (100 µl) and glycated hemoglobin (1 µl). Urine will be collected (50 ml) in the morning for further researches.

Study Type : Observational
Actual Enrollment : 80 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Low Grade Inflammation in Type 1 Diabetes Children
Study Start Date : April 2010
Primary Completion Date : July 2010
Study Completion Date : July 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Diabetes Type 1
U.S. FDA Resources

diabetes group
control group

Primary Outcome Measures :
  1. Increase of Interleukine 6 in group DTI versus control group [ Time Frame: Once at inclusion ]

Secondary Outcome Measures :
  1. Increase of others cytokines (IL1-beta, l'IL-4, l'IL-10 and TNF alpha) and increase of High sensitivity CRP in group DTI versus control group [ Time Frame: Once at inclusion ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   2 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
60 children in type 1 diabetes group and 30 children in control group

Inclusion Criteria:

Type 1 diabetes children group :

  • Children aged 2 to 17 years
  • Type 1 diabetes children

Controlled group :

  • Children aged 2 to 17 years
  • Brother or sister of type 1 diabetes children

Exclusion Criteria:

  • Per os or inhaled corticoid in the previous month of inclusion
  • Acute infectious disease in the previous week of inclusion
  • Other chronic disease than diabetes type1

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01099956

Children Hospital, Endocrinology Unit
Bordeaux, France, 33076
Sponsors and Collaborators
University Hospital, Bordeaux
Principal Investigator: Pascal BARAT, MD University Hospital, Bordeaux, France

Responsible Party: University Hospital, Bordeaux
ClinicalTrials.gov Identifier: NCT01099956     History of Changes
Other Study ID Numbers: CHUBX 2009/28
First Posted: April 8, 2010    Key Record Dates
Last Update Posted: October 25, 2011
Last Verified: October 2011

Keywords provided by University Hospital, Bordeaux:
type 1 diabetes
low grade inflammation

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 1
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Pathologic Processes
Autoimmune Diseases
Immune System Diseases